The IJGO Author Guidelines provide clear instructions for preparing manuscripts, before submitting them for consideration to ...
Each member society is committed to supporting FIGO's aim for women of the world to achieve the highest possible standards of physical, mental, reproductive and sexual health and wellbeing throughout ...
FIGO regularly issues statements and joint statements.
May 2019, FIGO released Guidelines to combat pre-eclampsia, and calls for all women to receive first-trimester screening. Read the Pre-eclampsia Guidelines here. 76,000 women and 500,000 babies die ...
We work together with our global network of world-renowned experts, to foster scientific and policy dialogues and disseminate the latest evidence in the field of women’s health and rights. Explore our ...
FIGO Divisions and Committees bring together experts from our member societies with other health care professionals focusing on specialist areas of obstetrics and gynaecology to encourage global ...
The Committee on Menstrual Disorders and Related Health Impacts focuses on the set of symptoms described as non-gestational abnormal uterine bleeding (AUB), including heavy menstrual bleeding (HMB).
FIGO regards reproductive choice, including access to safe abortion services, as a basic and non-negotiable tool for ensuring the human rights of every woman, not just in one region or country, but ...
Women’s health is underserved, understudied and often underresourced in innovations with disproportionately low research and development funding relative to the burden of morbidity and mortality and ...
FIGO’s 2024-2025 free webinar series tackles the most pressing issues on women’s health and rights. Organised by FIGO’s Divisions and Committees, FIGO’s webinar series brings together women’s health ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果